Effective pharmaceutical regulation protects public health by ensuring that medicines are of the required quality, safety, and efficacy.

Regulatory bodies require extractables and leachables assessments and testing to be conducted according to the most current regulations and best practices. New specifications are continually incorporated into the existing standards to ensure that medicines are appropriately manufactured, stored, distributed and dispensed. The ultimate goal is to guide the industry to effective and safe product development, hence protecting public health.  

Examples of new regulations are:

  • Revision of USP <661> Containers – Plastics. The extractables and leachables testing is now a component of USP <661.2> Plastic Packaging Systems for Pharmaceutical Use
  • General chapters for extractables and leachables testing:
    • USP <1663> Assessment of Extractbales Associated with Pharmaceutical Packaging/Delivery Systems
    • USP <1664> Assessment of Drug Product Leachables Associated with Pharmaceutical Packaging / Delivery Systems
  • Extractables Testing for Plastic Manufacturing Equipment – USP <665>, formerly <661.3>
  • Product Quality Research Institute (PQRI) best practices for parenteral and ophthalmic drug products – Final Recommendations Issued

When developing study plans for extractables and leachables testing, a “risk-based approach” is still expected to be taken. Lower risk dosage forms, such as oral and topical drug products, typically do not require formal extractables and leachables testing for the packaging and manufacturing components if their materials of construction comply with the Food and Drug Administration (FDA) food contact regulations. 

Exova’s scientists are active participants in the working groups that have developed the current extractables and leachables best practices such as PQRI, USP Expert Panels, ELSIE, and BPOG.

We know when actual extractables and leachables testing is expected and when an assessment report will be sufficient to meet the regulatory expectations. When testing is required, we can design efficient customized protocols to meet your specific needs.

  • Contact Us

    Whatever your query, we'll pass it on to our experts and respond within a very short space of time.
    More details
Pharmaceutical testing facilities

2395 Speakman Dr.,
Mississauga, ON L5K 1B3

Contact: Ben Vanasse - General Manager
Tel: +1 905 822 4111 (Ext: 10601)

Fax: +1 905 823 1446

Email: americas@exova.com

Click to view dynamic map

1300 First State Blvd, Suite C,
Wilmington, DE 19804

Contact: Waheed Sheikh - President
Tel: +1 302-636-0202

Fax: +1 302-636-0204

Email: americas@exova.com

Click to view dynamic map

9240 Santa Fe Springs Road,
Santa Fe Springs, CA 90670

Contact: Eric Lindsay - General Manager
Tel: +1 562-948-2225

Fax: +1 562-948-5850

Email: americas@exova.com

Click to view dynamic map